US Patent Litigations are now available. Check here

IP Verse

Peptide Synthesis

TechnologyPatent OppositionCompetitive Analysis

In the competitive field of Peptide Synthesis, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Peptide Synthesis technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Peptide Synthesis

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Top companies filing patent oppositions

Explore the top companies that have filed the most patent oppositions in the technology industry.

Last updated on: Jul 3, 2025
CompanyTotal Oppositions
STRAWMAN76
JAMES POOLE46
MAIWALD41
REGENERON PHARMACEUTICALS34
HOFFMANN EITLE30
MARGARET DIXON26
PFIZER22
BOULT WADE TENNANT22
KONIG SZYNKA TILMANN VON RENESSE21
SANOFI19

Top companies facing patent oppositions

Explore the top companies that have faced the most patent oppositions in the technology industry.

Last updated on: Jul 3, 2025
CompanyTotal Oppositions
GENENTECH81
F HOFFMANN LA ROCHE72
AMGEN61
REGENERON PHARMACEUTICALS54
CHUGAI SEIYAKU KABUSHIKI KAISHA52
NOVARTIS49
FHOFFMANN LA ROCHE45
BRISTOL MYERS SQUIBB36
SANOFI BIOTECHNOLOGY34
AMGEN RESEARCH MUNICH27

Top active law firms filing patent oppositions

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Last updated on: Jul 3, 2025
CompanyTotal Oppositions Filed
CARPMAELS & RANSFORD78
HOFFMANN EITLE73
MAIWALD70
MEWBURN ELLIS49
J A KEMP46
D YOUNG37
KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORF32
BOULT WADE TENNANT31
DORRIES, HANS ULRICH , DF-MP DORRIES FRANK-MOLNIA & POHLMAN30
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB24

Latest patents opposed in the Peptide Synthesis industry

Patent challenges are becoming increasingly common in the Peptide Synthesis industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Peptide Synthesis industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jul 3, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Peptide Synthesis industry

EP3283620Modified Gamma Delta Cells And Uses ThereofTC BIOPHARMMay 28, 2025MAIWALD
EP3487881Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 AntagonistsNOVARTISMay 21, 2025DEHMEL & BETTENHAUSEN PATENTANWALTE PARTMBB
EP3653645Interleukin-31 Monoclonal AntibodyZOETIS SERVICESMay 21, 2025MARGARET DIXON
EP3487881Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 AntagonistsNOVARTISMay 20, 2025NEUEFEIND
EP3653645Interleukin-31 Monoclonal AntibodyZOETIS SERVICESMay 20, 2025BOEHRINGER INGELHEIM VETMEDICA
EP3601367"Chimeric Molecules And Uses Thereof"THE UNIVERSITY OF QUEENSLANDMay 14, 2025JAMES POOLE
EP3684786Mutated Glycoprotein Of Vesicular Stomatitis VirusUNIVERSITE PARIS SUDMay 14, 2025BOULT WADE TENNANT
EP3970744Stable Secukinumab Injection And Preparation Method ThereforTONGHUA DONGBAO PHARMACEUTICALMay 14, 2025STRAWMAN
EP3638243Methods For Treating Myeloproliferative Neoplasm-Associated Myelofibrosis And AnemiaCELGENEMay 7, 2025MAIWALD
EP4209499Charged Depth Filtration Of Antigen-Binding ProteinsAMGENMay 7, 2025MAIWALD

Top patents facing oppositions in Peptide Synthesis industry

To stay ahead in the competitive Peptide Synthesis industry, companies are constantly innovating. Here are the top patents facing oppositions in the Peptide Synthesis industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jul 3, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2188302Nov 1, 2017Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH11
EP2462158Jan 10, 2018Method To Improve Virus Removal In Protein PurificationFHOFFMANN LA ROCHE11
EP2825558May 15, 2019Combination Therapy For The Treatment Of Ovarian CancerFHOFFMANN LA ROCHE10
EP2971040Sep 19, 2018Methods Of Cell CultureMOMENTA PHARMACEUTICALS10
EP3177645Feb 17, 2021Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLUDWIG MAXIMILIANS UNIVERSITT MNCHEN10
EP2791160Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNATX10
EP3616720Feb 17, 2021Pharmaceutical Composition For Cancer TreatmentOSAKA UNIVERSITY10
EP2586788Nov 29, 2017Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH9
EP2766040May 15, 2019Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabFHOFFMANN LA ROCHE9
EP3322731Jan 13, 2021Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL MYERS SQUIBB9